Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

273,598 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Apolipoprotein E and viral infection: Risks and Mechanisms.
Chen F, Ke Q, Wei W, Cui L, Wang Y. Chen F, et al. Among authors: wang y. Mol Ther Nucleic Acids. 2023 Jul 28;33:529-542. doi: 10.1016/j.omtn.2023.07.031. eCollection 2023 Sep 12. Mol Ther Nucleic Acids. 2023. PMID: 37588688 Free PMC article. Review.
Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.
Ge Z, Kan J, Gao X, Raza A, Zhang JJ, Mohydin BS, Gao F, Shao Y, Wang Y, Zeng H, Li F, Khan HS, Mengal N, Cong H, Wang M, Chen L, Wei Y, Chen F, Stone GW, Chen SL; ULTIMATE-DAPT investigators. Ge Z, et al. Among authors: wang y, wang m. Lancet. 2024 May 11;403(10439):1866-1878. doi: 10.1016/S0140-6736(24)00473-2. Epub 2024 Apr 7. Lancet. 2024. PMID: 38599220 Clinical Trial.
Circulating microRNAs as novel biomarkers for dilated cardiomyopathy.
Wang H, Chen F, Tong J, Li Y, Cai J, Wang Y, Li P, Hao Y, Tian W, Lv Y, Chong J, Yang J. Wang H, et al. Among authors: wang y. Cardiol J. 2017;24(1):65-73. doi: 10.5603/CJ.a2016.0097. Epub 2016 Oct 17. Cardiol J. 2017. PMID: 27748501 Free article.
Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer.
Jacobs SA, Wang Y, Abraham J, Feng H, Montero AJ, Lipchik C, Finnigan M, Jankowitz RC, Salkeni MA, Maley SK, Puhalla SL, Piette F, Quinn K, Chang K, Nagy RJ, Allegra CJ, Vehec K, Wolmark N, Lucas PC, Srinivasan A, Pogue-Geile KL. Jacobs SA, et al. Among authors: wang y. Breast Cancer Res. 2024 May 24;26(1):83. doi: 10.1186/s13058-024-01833-6. Breast Cancer Res. 2024. PMID: 38790033 No abstract available.
273,598 results
You have reached the last available page of results. Please see the User Guide for more information.